You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 15, 2024

THIOTHIXENE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Thiothixene patents expire, and what generic alternatives are available?

Thiothixene is a drug marketed by Am Therap, Amneal, Chartwell Rx, Epic Pharma Llc, Novitium Pharma, Rising, Watson Labs, Alpharma Us Pharms, Paco, Teva, Teva Pharms, and Hikma. and is included in twenty-two NDAs.

The generic ingredient in THIOTHIXENE is thiothixene hydrochloride. There are six drug master file entries for this compound. Additional details are available on the thiothixene hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for THIOTHIXENE?
  • What are the global sales for THIOTHIXENE?
  • What is Average Wholesale Price for THIOTHIXENE?
Drug patent expirations by year for THIOTHIXENE
Drug Prices for THIOTHIXENE

See drug prices for THIOTHIXENE

Recent Clinical Trials for THIOTHIXENE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Lindner Center of HOPEPhase 2
Janssen Scientific Affairs, LLC
Drug Safety and Effectiveness Network, Canada

See all THIOTHIXENE clinical trials

Pharmacology for THIOTHIXENE
Medical Subject Heading (MeSH) Categories for THIOTHIXENE

US Patents and Regulatory Information for THIOTHIXENE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva THIOTHIXENE HYDROCHLORIDE thiothixene hydrochloride CONCENTRATE;ORAL 071184-001 Jun 22, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs THIOTHIXENE thiothixene CAPSULE;ORAL 071628-001 Jun 25, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms THIOTHIXENE HYDROCHLORIDE thiothixene hydrochloride CONCENTRATE;ORAL 071554-001 Oct 16, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alpharma Us Pharms THIOTHIXENE HYDROCHLORIDE thiothixene hydrochloride CONCENTRATE;ORAL 070969-001 Oct 16, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.